New Orleans, LA2 Active Studies

Myalgic Encephalomyelitis Clinical Trials in New Orleans, LA

Find 2 actively recruiting myalgic encephalomyelitis clinical trials in New Orleans, LA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
342
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in New Orleans

About Myalgic Encephalomyelitis Clinical Trials in New Orleans

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 2 myalgic encephalomyelitis clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 342 participants. Research is being sponsored by SK Life Science, Inc., Delcath Systems Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in New Orleans — FAQ

Are there myalgic encephalomyelitis clinical trials in New Orleans?

Yes, there are 2 myalgic encephalomyelitis clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Orleans?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.

Are clinical trials in New Orleans free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 2 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov